Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederendpts.com
ENDPOINTS NEWS
Get the latest updates from ENDPOINTS NEWS directly as they happen.
Follow now 181 followers
Latest posts
Last updated 9 days ago
Inside Makary’s ouster; Another win for Lilly’s triple-G; and more
9 days ago
Welcome back to another edition of Endpoints Weekly! My usual co-author Nicole...
FDA clears Gilead's hepatitis D drug, four years after prior rejection
10 days ago
Gilead has at long last won US approval of its hepatitis D...
GOP lawmaker asks Trump administration to curb China biotech deals
10 days ago
A key Republican congressman asked the Trump administration to restrict the stream...
AstraZeneca wins EU backing for breast cancer drug, splitting with FDA panel
10 days ago
An AstraZeneca breast cancer drug received a positive opinion from European regulators...
How Utah’s AI prescribing experiment is going so far
10 days ago
Utah has released early data from a closely watched program that tests...
FDA grants Daiichi Sankyo and AstraZeneca’s Datroway a key breast cancer approval
10 days ago
The FDA has approved the TROP2-directed antibody-drug conjugate Datroway as a first-line...
Tender offer for Recordati; Sobi's gout drug passes Phase 3 test
10 days ago
Plus, news about Immunovant and Retro Biosciences 💸 CVC and GBL launch...
Why one health AI unicorn is giving away its service for free
10 days ago
As health tech gets more competitive, a strategy companies use to stand...
Novartis says Avidity's science could apply beyond muscular dystrophies
10 days ago
Novartis said it's working to get the most out of its $12...
Biogen, Denali to drop drug in non-genetic Parkinson’s after mid-stage study flop
10 days ago
Biogen and Denali Therapeutics’ LRRK2 inhibitor has flunked a Phase 2b trial...
Ibrance heirs, Gilead's Tubulis data and more at #ASCO26
10 days ago
All of the regular ASCO abstracts dropped Thursday afternoon, with the biggest...
Amgen CFO to follow David Reese into retirement; Josh Smiley is out at Zai Lab
10 days ago
→ Peter Griffith will be the second high-profile exec to leave Amgen...